Research Projects
We are living in extraordinary times where knowledge and technology advance rapidly. Advancement is achieved largely through the research efforts of scientists working tirelessly around the world. Still, it is important to remember that science is a never ending process and in the words of Albert Einstein:
“One thing I have learned in a long life: that all our science, measured against reality, is primitive and childlike and yet it is the most precious thing we have.” Albert Einstein (1879-1955) U. S. physicist, born in Germany.
In response to this need for advancing science through research CCC Biomedical Laboratory is joining the research efforts of scientists in Cyprus through autonomous research and as collaborators with scientists at the University of Cyprus, the University of Nicosia as well as medical doctors. Below is a summary of research projects CCC Biomedical laboratory was/is involved in:
Past Research Project
Homocysteine levels in high risk and apparently healthy individuals: The Cyprus Experience
PROJECT SUMMARY:
The overall objective of this project was:
- Determination of clinical usefulness of Homocysteine levels as a biological marker for cardiovascular diseases (CVDs).
Blood samples from apparently healthy individuals and CVD patients in Cyprus were collected and the Homocysteine levels were measured using the IMx homocysteine assay. The results of the current study suggest that there exists a clinical correlation of CVD with high Homocysteine levels. For more information read the entire article by clicking on this link: Homocysteine levels in high risk and apparently healthy individuals the Cyprus Experience
RESEARCH TEAM:
- CCC Biomedical Laboratory: Mr. C. Charilaou.
- Dr. P. Agathaggelou
On-going Research Projects
PROJECT 1: Evaluation of Biomarkers for cardiovascular disease in the Cypriot population
PROJECT SUMMARY:
The overall objectives of this study are:
- Determination of clinical usefulness of Homocysteine levels as a biological marker for cardiovascular diseases (CVDs).
- Determination of clinical usefulness of proBNP levels as a biological marker for CVDs.
Blood samples from apparently healthy individuals and CVD patients in Cyprus will be collected and the Homocysteine levels (measured using the IMx homocysteine assay) and proBNP levels (measured with Elexcys) will be determined. This study aims to expand on our past research and incorporate new biomarkers for CVD such as proBNP. RESEARCH TEAM:
- CCC Biomedical Laboratories: Mr. C. Charilaou, Dr. S. Nicolaou and Dr. P. Agathaggelou.
PROJECT 2: The prevalence of infectious diseases and the molecular epidemiology of HCV and HIV in intravenous drug users in Cyprus
Charis Charilaou Biomedical Laboratory is collaborating on a programme named "The prevalence of infectious diseases and the molecular epidemiology of HCV and HIV in intravenous drug users in Cyprus", headed by Dr. Leondios Kostrikis, head of the Laboratory of Biotechnology and Molecular Virology, University of Cyprus in collaboration with the Cyprus National Monitoring Centre for Drugs. The aim of the project is the determination of the prevalence and molecular epidemiology of infectious diseases in this high-risk population group.